EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Safety and Effectiveness of Repeated Botulinum Toxin A Intracavernosal Injections in Men with Erectile Dysfunction Unresponsive to Approved Pharmacological Treatments: Real-World Observational Data

François Giuliano, Pierre Denys iD, Charles Joussain

Toxins · 2023

DOI: 10.3390/toxins15060382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, 2023. Verfasst von François Giuliano und 2 weiteren Autor:innen. Beteiligte Einrichtung: Neuro-Uro-Andrology R. Poincare University Hospital, AP-HP, 104 Bvd R. Poincare, 92380 Garches, France. Hauptthemen laut MEDLINE: Erectile Dysfunction, Botulinum Toxins, Type A. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intracavernosal injections of botulinum toxin A (BTX/A ic) may be effective for difficult-to-treat erectile dysfunction (ED). This is a retrospective case series study of the effectiveness of repeated off-label BTX/A ic (onabotulinumtoxinA 100U, incobotulinumtoxinA 100U or abobotulinumtoxinA 500U) in men with ED and insufficient response to phosphodiesterase type 5 inhibitors (PDE5-Is) or prostaglandinE1 intracavernosal injections (PGE1 ICIs), defined as an International Index of Erectile Function-Erectile Function domain score (IIEF-EF) < 26 on treatment. Further injections were performed on patients’ requests, and the files of men who underwent at least two injections were reviewed. The response to BTX/A ic was defined as the achievement of the minimally clinically important difference in IIEF-EF adjusted to the severity of ED on treatment at baseline. Out of 216 men treated with BTX/A ic and PDE5-Is or PGE1-ICIs, 92 (42.6%) requested at least a second injection. The median time since the preceding injection was 8.7 months. In total, 85, 44 and 23 men received, respectively, two, three and four BTX/A ic. The overall response rate was 77.5%: 85.7% in men with mild ED, 79% for moderate ED and 64.3% for severe ED on treatment. The response increased with repeated injections: 67.5%, 87.5% and 94.7%, respectively, after the second, third and fourth injections. Post-injection changes in IIEF-EF were similar across injections. The time from injection to request for a further injection varied little. Four men reported penile pain at the time of injection (1.5% of all injections), and one experienced a burn at the penile crus. Repeated BTX/A injections combined with PDE5-Is or PGE1-ICIs produced an effective and durable response, with acceptable safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erectile DysfunctionBotulinum Toxins, Type AMaleHumansPenile ErectionAlprostadilRetrospective StudiesPhosphodiesterase 5 InhibitorsTreatment Outcome

Stichwörter der Autor:innen

abobotulinumtoxinAincobotulinumtoxinA phosphodiesterase type 5 inhibitorsonabotulinumtoxinAprostaglandinE1

Substanzen

AlprostadilBotulinum Toxins, Type APhosphodiesterase 5 Inhibitors

Autor:innen und Institutionen

  • Neuro-Uro-Andrology R. Poincare University Hospital, AP-HP, 104 Bvd R. Poincare, 92380 Garches, France.
  • UMR 1179, Inserm Faculty of Medicine, Versailles Saint Quentin University, Paris Saclay, 78180 Montigny le Bretonneux, France.

ORCID-Profile: Pierre Denys

Zitieren

APA

Giuliano, F., Denys, P., & Joussain, C. (2023). Safety and Effectiveness of Repeated Botulinum Toxin A Intracavernosal Injections in Men with Erectile Dysfunction Unresponsive to Approved Pharmacological Treatments: Real-World Observational Data. Toxins. https://doi.org/10.3390/toxins15060382

Vancouver

Giuliano F, Denys P, Joussain C. Safety and Effectiveness of Repeated Botulinum Toxin A Intracavernosal Injections in Men with Erectile Dysfunction Unresponsive to Approved Pharmacological Treatments: Real-World Observational Data. Toxins. 2023. doi:10.3390/toxins15060382

BibTeX
@article{Giuliano2023,
  author = {Giuliano, François and Denys, Pierre and Joussain, Charles},
  title = {Safety and Effectiveness of Repeated Botulinum Toxin A Intracavernosal Injections in Men with Erectile Dysfunction Unresponsive to Approved Pharmacological Treatments: Real-World Observational Data},
  journal = {Toxins},
  year = {2023},
  doi = {10.3390/toxins15060382}
}
Kostenlos starten →